ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 89 filers reported holding ADURO BIOTECH INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,071,000 | -49.4% | 1,010,000 | +251.0% | 0.11% | -39.2% |
| Q3 2018 | $2,115,000 | +2.1% | 287,776 | -2.8% | 0.19% | -7.9% |
| Q2 2018 | $2,072,000 | -72.4% | 295,965 | -63.3% | 0.20% | -73.4% |
| Q1 2018 | $7,501,000 | +281.1% | 806,534 | +336.5% | 0.76% | +204.0% |
| Q3 2017 | $1,968,000 | -42.5% | 184,764 | -38.4% | 0.25% | -52.9% |
| Q2 2017 | $3,420,000 | -59.8% | 300,000 | -59.8% | 0.53% | -68.9% |
| Q4 2016 | $8,503,000 | +36.5% | 745,886 | +48.8% | 1.71% | +45.5% |
| Q3 2016 | $6,229,000 | +7.2% | 501,155 | -2.4% | 1.17% | -5.2% |
| Q2 2016 | $5,809,000 | – | 513,603 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 2,106,734 | $40,807,000 | 12.39% |
| Rock Springs Capital Management LP | 415,000 | $8,039,000 | 0.65% |
| CLOUGH CAPITAL PARTNERS L P | 592,697 | $11,481,000 | 0.50% |
| NJ State Employees Deferred Compensation Plan | 53,300 | $1,032,000 | 0.22% |
| Orbimed Advisors | 1,065,522 | $20,639,000 | 0.21% |
| Point72 Asset Management, L.P. | 845,700 | $16,381,000 | 0.13% |
| LMCG INVESTMENTS, LLC | 244,382 | $4,734,000 | 0.10% |
| EverPoint Asset Management, LLC | 150,000 | $2,906,000 | 0.08% |
| M&T BANK CORP | 566,560 | $10,974,000 | 0.08% |
| GLOBEFLEX CAPITAL L P | 15,200 | $294,000 | 0.06% |